DLP 3D printing of hyperelastic photocurable perivascular scaffolds enabling patient-specific vascular remodeling
Acta Biomaterialia · 2025-09 · 203 · 381-398
DOI: 10.1016/j.actbio.2025.07.048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2025-09. Verfasst von Ning Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Engineering, Zhengzhou University, Zhengzhou, 450001, China; National Center for International Research of Micro-Nano…. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Tissue Scaffolds, Vascular Remodeling. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 95 Literaturangaben.
Abstract (Originalsprache)
Photopolymerization-based 3D printing, enabled the fabrication of complex, patient-specific scaffolds with high resolution and spatial precision. However, most photocurable biomaterials exhibited mechanical mismatch with soft tissues such as vascular, cartilage, and tendon tissues. To address this limitation, we developed a biodegradable and elastomeric resin (A-PLCL/4SH), composed of methacrylate-functionalized poly(L-lactide-co-ε-caprolactone) (A-PLCL) and pentaerythritol tetra(3-mercaptopropionate) (PETA-4SH), which enabled high-fidelity digital light processing (DLP) 3D printing. Using this resin, we fabricated a dual-layered perivascular scaffold (BioShell) for arteriovenous fistula (AVF) intervention, that integrating mechanical support, hemodynamic optimization, and localized drug delivery. BioShell consisted of a DLP-printed A-PLCL/4SH outer layer (BioCore) and an inner layer of methacrylated silk fibroin (SilMA) hydrogel, which enabled dual-phase release of 4‑hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPOL) and rapamycin (RAPA). The initial burst release of TEMPOL scavenged reactive oxygen species (ROS) and mitigated early inflammation, while sustained TEMPOL/RAPA release inhibited vascular smooth muscle cell (VSMC) proliferation and neointimal hyperplasia (NIH). Compared to metallic wraps (e.g., VEST/VasQ) and traditional electrospun scaffolds, BioShell uniquely integrated compliance-matched elasticity, programmable drug release, and patient-specific fabrication. Fluid-structure interaction simulations confirmed improved hemodynamics and reduced wall stress. In vitro and in vivo evaluations demonstrated effective ROS clearance, suppressed VSMC proliferation, and enhanced vascular remodeling. Overall, BioShell represents a modular and clinically relevant platform for AVF therapy and broader soft tissue reconstruction. STATEMENT OF SIGNIFICANCE: We developed a dual-layer perivascular scaffold (BioShell) that combined mechanical support with programmable drug delivery. By integrating a 3D printed elastic outer shell (A-PLCL/4SH) with an injectable SilMA hydrogel layer, BioShell achieved high compliance matching with native vessels, overcoming the stiffness and limited therapeutic functionality of metallic and electrospun wraps. In vivo, BioShell/RAPA reduced stenosis by ∼77 % compared to control and significantly outperformed non-drug-loaded scaffolds (p < 0.001) in promoting vascular remodeling. This modular, biodegradable system offered a translational strategy for vascular reconstruction and soft tissue repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials Science and Engineering, Zhengzhou University, Zhengzhou, 450001, China; National Center for International Research of Micro-Nano Molding Technology, Zhengzhou University, Zhengzhou, 450001, China.
- Blood Purification Center, Zhengzhou University People's Hospital, Zhengzhou, 450003, China.
- National Center for International Research of Micro-Nano Molding Technology, Zhengzhou University, Zhengzhou, 450001, China; School of Mechanics and Safety Engineering, Zhengzhou University, Zhengzhou, 450001, China.
- Blood Purification Center, Zhengzhou University People's Hospital, Zhengzhou, 450003, China. Electronic address: zhtzzu@126.com.
- National Center for International Research of Micro-Nano Molding Technology, Zhengzhou University, Zhengzhou, 450001, China; School of Mechanics and Safety Engineering, Zhengzhou University, Zhengzhou, 450001, China. El…
Zitieren
APA
Zhang, N., Lu, Y., Li, J., Xiao, Z., Lyu, Y., Liu, Y., Wan, J., Wang, Z., Li, X., Zhang, H., Wang, X., & Li, Q. (2025). DLP 3D printing of hyperelastic photocurable perivascular scaffolds enabling patient-specific vascular remodeling. Acta Biomaterialia, 203, 381-398. https://doi.org/10.1016/j.actbio.2025.07.048
Vancouver
Zhang N, Lu Y, Li J, Xiao Z, Lyu Y, Liu Y, et al. DLP 3D printing of hyperelastic photocurable perivascular scaffolds enabling patient-specific vascular remodeling. Acta Biomaterialia. 2025;203:381-398. doi:10.1016/j.actbio.2025.07.048
BibTeX
@article{Zhang2025,
author = {Zhang, Ning and Lu, Yang and Li, Jiawei and Xiao, Zhenmeng and Lyu, Yingzheng and Liu, Yajing and Wan, Jingyi and Wang, Ziyi and Li, Xiaomeng and Zhang, Hongtao and Wang, Xiaofeng and Li, Qian},
title = {DLP 3D printing of hyperelastic photocurable perivascular scaffolds enabling patient-specific vascular remodeling},
journal = {Acta Biomaterialia},
year = {2025},
volume = {203},
pages = {381--398},
doi = {10.1016/j.actbio.2025.07.048}
}
EUVIMED